Learn about the recent landmark mid-term elections and their influence on the health policy agenda for the 112th Congress. This webinar will feature Jeffrey J. Kimbell, a lobbyist who represents the medical technology and life sciences industry on Captiol Hill. He will discuss the major health policy issues that will affect healthcare and the industry over the next 12-18 months.

Jeffrey J Kimbell , President of Jeffrey J. Kimbell & Associates, represents clients in the life sciences community seeking legislative remedies for their needs. Kimbell & Associates was founded in 1998 and has since grown to include five full-time lobbyists and/or policy experts in the field of medical devices, pharmaceuticals, biodefense, and biotechnology. The firm has 17 hand-selected clients, all in the life sciences space.

Three years after establishing his firm, in January 2001, Mr. Kimbell was named to President George W. Bush's Transition Team Advisory Committee for the U.S. Department of Health and Human Services (HHS). He was the only consultant to serve on the Committee.